Frederick Frank | |
---|---|
Born | Salt Lake City, Utah, U.S. | May 31, 1932
Died | September 11, 2021 | (aged 89)
Alma mater | Yale University, Stanford Graduate School of Business |
Spouse | Mary C. Tanner[1][2][3] |
Awards | Richard J. Bolte Sr. Award |
Scientific career | |
Fields | Investment banking, biotechnology |
Institutions | EVOLUTION Life Science Partners, Peter J. Solomon Company, Lehman Brothers, Barclays Capital |
External videos | |
---|---|
“BIO at 25-Jim Greenwood and Frederick Frank Discuss Early Biotech investment”, Biotechnology Innovation Organization, 2018 |
Frederick Frank (May 31, 1932 – September 11, 2021) was an American banker, with more than 50 years of experience on Wall Street. He is considered the first investment banker to have specialized in the areas of biotechnology, pharmaceuticals, and health care services.[4][5]
As of 2014, Frank became a founder and chair of EVOLUTION Life Science Partners. He previously served as vice chairman of Lehman Brothers, Barclays Capital, and the Peter J. Solomon Company.[4] He is credited as lead underwriter for over 125 IPOs and as a negotiator in over 75 mergers and acquisitions.[6] Frank was chosen as one of the top 100 contributors to biotechnology in 2005.[5][7]
Institute
was invoked but never defined (see the help page).Greenwood
was invoked but never defined (see the help page).